Actively Recruiting
Post Intensive Care Unit Atrial Fibrillation
Led by Centre Hospitalier Universitaire de Besancon · Updated on 2024-02-01
150
Participants Needed
1
Research Sites
171 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire de Besancon
Lead Sponsor
B
Biotronik SE & Co. KG
Collaborating Sponsor
AI-Summary
What this Trial Is About
Atrial fibrillation (AF) is a common heart rhythm disorder in the intensive care unit (ICU). It can be precipitated by multiple factors but it is unclear whether AF persists after discharge from the ICU, and long term. This study will investigate whether AF recurs up to one year after ICU discharge.
CONDITIONS
Official Title
Post Intensive Care Unit Atrial Fibrillation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years
- New onset atrial fibrillation diagnosed in the ICU by 12 lead ECG or episode lasting at least 30 seconds
- Hospitalized in the ICU with either orotracheal intubation for mechanical ventilation and/or treatment with vasopressors or inotropic agents
- Written informed consent provided
- Affiliated with a social security regime or beneficiary of one
You will not qualify if you...
- History of atrial fibrillation before ICU admission
- Admission to ICU after cardiothoracic surgery
- Life expectancy less than 12 months
- Under legal or judicial protection
- No social security coverage
- Currently within the exclusion period of another clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Universitaire de Besancon
Besançon, France, 25000
Actively Recruiting
Research Team
C
Charles Monnin, MD
CONTACT
E
Elise Robert
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here